Article
Not so sweet: autoimmune diabetes mellitus on triple therapy for chronic hepatitis C infection.
Diabetic medicine : a journal of the British Diabetic Association - 1 Feb 2015
Blanchard E, Vickers C R, Samaras K
Abstract excerpt
BACKGROUND: Triple therapy with pegylated interferon, ribavirin and a protease inhibitor has proven efficacy in hepatitis C infection and is currently the standard of care. Interferon-based therapies have been, rarely, associated with the development of Type 1 diabetes mellitus, but few cases have yet been reported in triple therapy for hepatitis C. CASE REPORT: We describe a case of autoimmune Type 1 diabetes...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
